Advanced glycation end products in uremia.
The term "advanced glycation end products" (AGEs) stands for a heterogeneous group of amino acid derivatives that are formed via glycation processes between peptide-bound lysine or arginine derivatives and carbonyl compounds, processes originally known from food systems as "Maillard reactions." AGEs accumulate in plasma and tissues with advancing age, diabetes, and particular renal failure. In vivo and in vitro studies indicate that AGEs represent an important class of uremic toxins. This review focuses on the chemistry behind the formation of AGEs, possible mechanisms underlying the accumulation of AGEs in uremia, clinical and therapeutic implications, and possible nutritional consequences.
Henle
Thomas
T
Institute of Food Chemistry, Technical University of Dresden, Germany.
Miyata
Toshio
T
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D017127:Glycation End Products, Advanced / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007661:Ketoses / Q000096:biosynthesis; D015416:Maillard Reaction; D009752:Nutritional Status; D014511:Uremia / Q000378:metabolism*
D000596:Amino Acids; D017127:Glycation End Products, Advanced; D007661:Ketoses